Correcting the drug development paradigm for glioblastoma requires serial tissue sampling

Kirit Singh, Kelly M Hotchkiss, Ian F Parney, John De Groot, Solmaz Sahebjam, Nader Sanai, Michael Platten, Evanthia Galanis, Michael Lim, Patrick Y Wen, Giuseppe Minniti, Howard Colman, Timothy F Cloughesy, Minesh P Mehta, Marjolein Geurts, Isabel Arrillaga-Romany, Annick Desjardins, Kirk Tanner, Susan Short, David AronsElizabeth Duke, Wolfgang Wick, Stephen J Bagley, David M Ashley, Priya Kumthekar, Roel Verhaak, Anthony J Chalmers, Anoop P Patel, Colin Watts, Peter E Fecci, Tracy T Batchelor, Michael Weller, Michael A Vogelbaum, Matthias Preusser, Mitchel S Berger, Mustafa Khasraw

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)2402-2405
Number of pages4
JournalNature medicine
Volume29
Issue number10
DOIs
StatePublished - Sep 2023

Keywords

  • Humans
  • Glioblastoma/drug therapy
  • Brain Neoplasms/drug therapy
  • Drug Development

Cite this